Related Experiment Video
Updated: Feb 8, 2026

A Simplified Method for Generating Kidney Organoids from Human Pluripotent Stem Cells
Published on: April 13, 2021
Applications of kidney organoids derived from human pluripotent stem cells
Yong Kyun Kim1,2, Sun Ah Nam1,2, Chul Woo Yang2,3
1Cell Death Disease Research Center, The Catholic University of Korea, Seoul, Korea.
Abstract:
The establishment of protocols to differentiate kidney organoids from human pluripotent stem cells provides potential applications of kidney organoids in regenerative medicine. Modeling of renal diseases, drug screening, nephrotoxicity testing of compounds, and regenerative therapy are attractive applications. Although much progress still remains to be made in the development of kidney organoids, recent advances in clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated system 9 (Cas9) genome editing and three-dimensional bioprinting technologies have contributed to the application of kidney organoids in clinical fields. In this section, we review recent advances in the applications of kidney organoids to kidney disease modelling, drug screening, nephrotoxicity testing, and regenerative therapy.
Insights
Human pluripotent stem cells are used to create kidney organoids for regenerative medicine. Advances in genome editing and bioprinting enhance their use in disease modeling, drug screening, and regenerative therapy.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Regenerative Medicine
Background:
- Human pluripotent stem cells can be differentiated into kidney organoids.
- Kidney organoids offer potential for regenerative medicine applications.
- Significant progress has been made in kidney organoid development.
Purpose of the Study:
- To review recent advances in kidney organoid applications.
- To highlight the use of kidney organoids in clinical fields.
- To discuss kidney organoids in disease modeling, drug screening, and regenerative therapy.
Main Methods:
- Review of recent scientific literature.
- Focus on advancements in clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated system 9 (Cas9) genome editing.
- Integration of three-dimensional bioprinting technologies.
Main Results:
- Kidney organoids show promise in modeling renal diseases.
- Applications include drug screening and nephrotoxicity testing.
- Regenerative therapy is a key potential application.
Conclusions:
- Kidney organoids are valuable tools for kidney research and therapy.
- CRISPR-Cas9 and 3D bioprinting accelerate clinical applications.
- Further development holds significant therapeutic potential.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Embryonic Stem Cells
Clinical Applications of Epidermal Stem Cells
Kidney Structure
Adult Stem Cells

